175 related articles for article (PubMed ID: 11514038)
1. Graphical search for two-stage designs for phase II clinical trials.
Jung SH; Carey M; Kim KM
Control Clin Trials; 2001 Aug; 22(4):367-72. PubMed ID: 11514038
[TBL] [Abstract][Full Text] [Related]
2. Admissible two-stage designs for phase II cancer clinical trials.
Jung SH; Lee T; Kim K; George SL
Stat Med; 2004 Feb; 23(4):561-9. PubMed ID: 14755389
[TBL] [Abstract][Full Text] [Related]
3. Minimax and admissible adaptive two-stage designs in phase II clinical trials.
Shan G; Zhang H; Jiang T
BMC Med Res Methodol; 2016 Aug; 16():90. PubMed ID: 27485595
[TBL] [Abstract][Full Text] [Related]
4. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
5. Stochastically curtailed phase II clinical trials.
Ayanlowo AO; Redden DT
Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
[TBL] [Abstract][Full Text] [Related]
6. Optimal adaptive two-stage designs for early phase II clinical trials.
Shan G; Wilding GE; Hutson AD; Gerstenberger S
Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
[TBL] [Abstract][Full Text] [Related]
7. Optimal flexible designs in phase II clinical trials.
Chen TT; Ng TH
Stat Med; 1998 Oct; 17(20):2301-12. PubMed ID: 9819829
[TBL] [Abstract][Full Text] [Related]
8. Adaptive two-stage designs in phase II clinical trials.
Banerjee A; Tsiatis AA
Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
[TBL] [Abstract][Full Text] [Related]
9. Optimal adaptive two-stage designs for phase II cancer clinical trials.
Englert S; Kieser M
Biom J; 2013 Nov; 55(6):955-68. PubMed ID: 23868324
[TBL] [Abstract][Full Text] [Related]
10. Modified Simon's minimax and optimal two-stage designs for single-arm phase II cancer clinical trials.
Kim J; Schell MJ
Oncotarget; 2019 Jul; 10(42):4255-4261. PubMed ID: 31303960
[TBL] [Abstract][Full Text] [Related]
11. A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials.
Jin H; Wei Z
Contemp Clin Trials; 2012 Nov; 33(6):1255-60. PubMed ID: 22772088
[TBL] [Abstract][Full Text] [Related]
12. Optimal, minimax and admissible two-stage design for phase II oncology clinical trials.
Qin F; Wu J; Chen F; Wei Y; Zhao Y; Jiang Z; Bai J; Yu H
BMC Med Res Methodol; 2020 May; 20(1):126. PubMed ID: 32434577
[TBL] [Abstract][Full Text] [Related]
13. Optimal three-stage designs for phase II cancer clinical trials.
Chen TT
Stat Med; 1997 Dec; 16(23):2701-11. PubMed ID: 9421870
[TBL] [Abstract][Full Text] [Related]
14. Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.
Zhao J; Yu M; Feng XP
BMC Med Res Methodol; 2015 Jun; 15():48. PubMed ID: 26048655
[TBL] [Abstract][Full Text] [Related]
15. Phase II cancer clinical trials with heterogeneous patient populations.
Jung SH; Chang MN; Kang SJ
J Biopharm Stat; 2012; 22(2):312-28. PubMed ID: 22251176
[TBL] [Abstract][Full Text] [Related]
16. Balanced two-stage designs for phase II clinical trials.
Ye F; Shyr Y
Clin Trials; 2007; 4(5):514-24. PubMed ID: 17942467
[TBL] [Abstract][Full Text] [Related]
17. Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.
Jung SH
Contemp Clin Trials; 2015 May; 42():9-17. PubMed ID: 25749311
[TBL] [Abstract][Full Text] [Related]
18. Two-stage k-sample designs for the ordered alternative problem.
Shan G; Hutson AD; Wilding GE
Pharm Stat; 2012; 11(4):287-94. PubMed ID: 22408050
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II trials with a prospective control.
Jung SH
Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
[TBL] [Abstract][Full Text] [Related]
20. A modification of Simon's optimal design for phase II trials when the criterion is median sample size.
Hanfelt JJ; Slack RS; Gehan EA
Control Clin Trials; 1999 Dec; 20(6):555-66. PubMed ID: 10588296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
